Skip to main navigation
Skip to search
Skip to main content
Maastricht University Home
Support & FAQ
Link opens in a new tab
Search content at Maastricht University
Home
Researchers
Publications
Activities
Press/Media
Prizes
Organisations
Dataset/Software
Projects
Senescence in pulmonary arterial hypertension: is there a link?
Khrystyna O Semen
*
, Aalt Bast
*
Corresponding author for this work
University College Venlo
Adaptive responses in relation to health effect and safety of nutrition
NUTRIM - Healthy Ageing
Research output
:
Contribution to journal
›
(Systematic) Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Senescence in pulmonary arterial hypertension: is there a link?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Biochemistry, Genetics and Molecular Biology
Gelatinase A
100%
MMP2
100%
Upregulation
100%
Interleukin 6
100%
Cell Cycle Checkpoint
100%
Clinical Study
100%
Cell Cycle
100%
Cell Cycle Arrest
100%
B Cell
100%
P53
100%
Programmed Cell Death
100%
Lung Hemodynamics
100%
Keyphrases
Senescence
100%
Pulmonary Arterial Hypertension
100%
Hypertension Patients
25%
Senolytics
25%
Senescence Biomarkers
25%
Cardiovascular Disease
12%
Clinically Significant
12%
Interleukin-6
12%
Treatment Strategy
12%
Effective Treatment
12%
B-cell Lymphoma 2 (Bcl-2)
12%
Matrix metalloproteinase-2 (MMP-2)
12%
Vascular Remodeling
12%
Tumor Protein p53 (TP53)
12%
Associated Phenotypes
12%
P16INK4a
12%
Clinically Meaningful Outcomes
12%
Modulating Effect
12%
Cell Cycle Arrest
12%
Pathobiology
12%
Senescence-associated
12%
Cellular Senescence
12%
Cell Cycle Inhibitors
12%
Apoptosis Resistance
12%
Pulmonary Hemodynamics
12%
Promising Target
12%
Pathobiological Mechanisms
12%
Therapeutic Applications
12%
P21Cip1
12%
Young People
12%
Resistance Biomarkers
12%
INIS
hypertension
100%
biological markers
37%
patients
25%
cell cycle
25%
diseases
12%
tumors
12%
increasing
12%
matrices
12%
cardiovascular diseases
12%
reviews
12%
design
12%
phenotype
12%
apoptosis
12%
production
12%
lymphomas
12%
proteins
12%
in vivo
12%
exploration
12%
people
12%
depth
12%
interleukins
12%
therapeutic uses
12%
Medicine and Dentistry
Pulmonary Hypertension
100%
Biological Marker
37%
Interleukin 6
12%
Clinical Study
12%
Cardiovascular Disease
12%
Programmed Cell Death
12%
Upregulation
12%
B-Cell Lymphoma
12%
Cell Cycle
12%
Protein P53
12%
Gelatinase A
12%
Vascular Remodeling
12%
Cellular Senescence
12%
Cell Cycle Checkpoint
12%
Cell Cycle Arrest
12%
Lung Hemodynamics
12%
Diseases
12%
Therapeutic Use
12%
Pharmacology, Toxicology and Pharmaceutical Science
Pulmonary Hypertension
100%
Biological Marker
37%
Interleukin 6
12%
Clinical Study
12%
Protein P53
12%
Gelatinase A
12%
B Cell Lymphoma
12%
Therapeutic Use
12%
Vascular Remodeling
12%
Cardiovascular Disease
12%
Diseases
12%